TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
PROK

ProKidney Corp.

Healthcare · Biotechnology

1.60$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

ProKidney Corp. (PROK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 249 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PROK
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
452 421 388 499 475 441 406 372 352 336 293 249
406 374 340 450 430 396 360 324 300 281 235 190
191 61 84 215 108 99 98 85 95 109 102 75
396 363 329 432 407 358 328 295 272 270 225 182
0.7 1.4 1.9 2.7 5.1 2.4 1.8 1.8 1.2 1.1 1.0 1.0
9.4 – – – – – – – – – – –
0.1 – – – – – – – – – – –
24 29 25 27 31 39 36 33 33 35 30 26
21 25 19 21 25 36 33 28 29 31 26 23
0.7 0.8 1.1 1.0 1.1 0.8 0.9 0.9 1.0 1.1 1.1 1.1
4.5 5.1 3.4 2.9 2.9 3.6 3.1 2.4 1.9 0.9 2.6 1.6
-1,093 -1,103 -1,096 -972 -980 -995 -999 -1,003 -1,008 -1,011 -1,024 -884
-1,134 -1,140 -1,149 -1,162 -1,180 -1,201 -1,218 -1,234 -1,251 -1,270 -1,290 -1,318
62 60 61 76 126 128 129 131 135 140 142 187

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?